SCIESCOPUSQ2
Crohns & Colitis 360
OXFORD UNIV PRESS, United Kingdom
Crohns & Colitis 360 is an academic journal published by OXFORD UNIV PRESS (United Kingdom). Identifiers: eISSN 2631-827X. Indexed in SCIE, SCOPUS. Metrics: JIF 2.6, CiteScore 3.2, SJR 0.924, SNIP 0.70. Subject areas: GASTROENTEROLOGY & HEPATOLOGY. tlooto lists 648 papers from this journal.
CiteScore
3.20
Scopus citation metric
SJR
0.924
SCImago rank
SNIP
0.70
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2631-827X
- Abbreviation
- CROHNS COLITIS 360
- Publisher
- OXFORD UNIV PRESS
- Country
- United Kingdom
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2715 Gastroenterology
Papers in this journal
Recent papers
- Stoma formation and associated risk factors in patients with Crohn′s disease in an Austrian tertiary referral hospital: A retrospective explorative study of long-term follow-up
2026
- Clinical Characterization and Healthcare Burden of Difficult-to-Treat Inflammatory Bowel Disease in Latin America: a real-world registry-based study
2026
- Patients’ attitudes to disease prevention in inflammatory bowel disease: a US-based survey
2026
- Association between serum leucine-rich alpha-2-glycoprotein levels and characteristic enteroclysis findings in small intestinal Crohn’s disease
2026
- Dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn’s disease
2026
Most cited papers
- Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
2022 · 69 citations
- Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients
2021 · 47 citations
- Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis
2023 · 46 citations
- Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers
2020 · 43 citations
- The Impact of Crohn’s Perianal Fistula on Quality of Life: Results of an International Patient Survey
2023 · 36 citations